Monique Collins
Family · Porterville, CANPI 1154885853
Payments from drug & device makers
Across 116 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$556
- Boehringer Ingelheim$395
- AstraZeneca$280
- Biohaven Pharmaceuticals, Inc.$240
- Biohaven Pharmaceutical Holding Company Ltd.$158
- Bayer$153
- plus $829 from 14 others
What the payments were for
- Food & beverage$2,611100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $556 |
| Boehringer Ingelheim | 19 | $395 |
| AstraZeneca | 6 | $280 |
| Biohaven Pharmaceuticals, Inc. | 2 | $240 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $158 |
| Bayer | 8 | $153 |
| GSK | 6 | $120 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Pfizer | 5 | $98 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $98 |
| Lilly USA, LLC | 6 | $94 |
| Novo Nordisk | 3 | $62 |
| Amgen | 3 | $57 |
| Dexcom, Inc. | 2 | $52 |
| Agile Therapeutics, Inc. | 2 | $35 |
| Pulmonx Corporation | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Exact Sciences | 1 | $16 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$240
- AIRSUPRA$150
- REXULTI$120
How this compares
$2,611 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 16 | $26,609 |
| OzempicSemaglutide | 23 | $19,369 |
| Spiriva RespimatTiotropium Bromide | 14 | $6,371 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $1,014 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $985 |
| Omeprazole | 50 | $368 |
| Gabapentin | 30 | $307 |
| Hydroxyzine Hcl | 24 | $300 |
| Losartan Potassium | 20 | $251 |
| Metoprolol Succinate | 15 | $231 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $213 |
| Levothyroxine Sodium | 40 | $200 |
| Lisinopril | 43 | $172 |
| Atorvastatin Calcium | 48 | $154 |
| Tizanidine Hcl | 17 | $153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $62 | $45,97839 claims |
| Boehringer IngelheimSpiriva Respimat | $395 | $6,37114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.
Other family in Porterville
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.